skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study

Li, Wenqi ; Chang, Yu ; Liu, Xiyang ; Chen, Ziqi ; Sun, Jinmiao ; Geng, Zurui ; Zhang, Mingzhi ; Zhang, Lei

Annals of hematology, 2024-06, Vol.103 (6), p.2003-2012 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
2
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

Tai, W. M. ; Chung, J. ; Tang, P. L. ; Koo, Y. X. ; Hou, X. ; Tay, K. W. ; Quek, R. ; Tao, M. ; Lim, S. T.

Annals of hematology, 2011-07, Vol.90 (7), p.809-818 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study

Schwaner, Ingo ; Kuhn, Thomas ; Losem, Christoph ; Wolff, Thomas ; Otremba, Burkhard ; Zaiss, Matthias ; Hülsenbeck, Johannes ; Famulla, Kirsten ; Nösslinger, Thomas ; Rossi, Davide

Annals of hematology, 2024-06, Vol.103 (6), p.2013-2020 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma

Fargier, Emilie ; Ranchon, Florence ; Huot, Laure ; Guerre, Pascale ; Safar, Violaine ; Dony, Arthur ; Hequet, Nathalie ; Bachy, Emmanuel ; Savouroux, Stéphane ; Fronteau, Clémentine ; Tomaré, Patrick ; Tournamille, Jean-François ; Schwiertz, Vérane ; Vantard, Nicolas ; Le Gouill, Steven ; Gyan, Emmanuel ; Salles, Gilles ; Rioufol, Catherine

Annals of hematology, 2018, Vol.97 (1), p.123-131 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
5
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

González-Barca, Eva ; Capote, Francisco Javier ; Gómez-Codina, Jose ; Panizo, Carlos ; Salar, Antonio ; Sancho, Juan-Manuel ; López, Andres ; Briones, Javier ; Muñoz, Andres ; Encuentra, Maite ; Mercadal, Santiago ; Domingo-Domenech, Eva ; de Sevilla, Alberto Fernández

Annals of hematology, 2021-04, Vol.100 (4), p.1023-1029 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives
Material Type:
Artigo 		Adicionar ao Meu Espaço

Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives

Vianelli, Nicola ; Auteri, Giuseppe ; Buccisano, Francesco ; Carrai, Valentina ; Baldacci, Erminia ; Clissa, Cristina ; Bartoletti, Daniela ; Giuffrida, Gaetano ; Magro, Domenico ; Rivolti, Elena ; Esposito, Daniela ; Podda, Gian Marco ; Palandri, Francesca

Annals of hematology, 2022-05, Vol.101 (5), p.963-978 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects
Material Type:
Artigo 		Adicionar ao Meu Espaço

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects

Ghafoor, Bushra ; Masthan, Shameera Shaik ; Hameed, Maha ; Akhtar, Hafiza Huda ; Khalid, Azeem ; Ghafoor, Sana ; Allah, Hassan min ; Arshad, Mohammad Mohsin ; Iqbal, Iman ; Iftikhar, Ahmad ; Husnain, Muhammad ; Anwer, Faiz

Annals of hematology, 2024-06, Vol.103 (6), p.1859-1876 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
8
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings

Czuczman, Myron S. ; Goy, A. ; Lamonica, D. ; Graf, D. A. ; Munteanu, M. C. ; van der Jagt, R. H.

Annals of hematology, 2015-12, Vol.94 (12), p.2025-2032 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study

Berger, Tamar ; Shochat, Tzippy ; Aumann, Shlomzion ; Nachmias, Boaz ; Goldschmidt, Neta ; Horesh, Nurit ; Harel, Reut ; Aviv, Ariel ; Shmerts, Ella ; Abadi, Uri ; Shimony, Shai ; Raanani, Pia ; Gafter‑Gvili, Anat ; Gurion, Ronit

Annals of hematology, 2023-08, Vol.102 (8), p.2127-2136 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
10
Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia
Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Possible hampered effectiveness of second-line treatment with rituximab-containing chemotherapy without signs of rituximab resistance: a population-based study among patients with chronic lymphocytic leukemia

van der Straten, Lina ; Kater, Arnon P. ; Doorduijn, Jeanette K. ; van den Broek, Esther C. ; Posthuma, Eduardus F.M. ; Dinmohamed, Avinash G. ; Levin, Mark-David

Annals of hematology, 2020-05, Vol.99 (5), p.1081-1091 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.